Singleton, K. D., Ziegler, T. R., Luo, M., Fernandez-Estivariz, C., & Wischmeyer, P. E. (2004). INTRAVENOUS GLUTAMINE INCREASES SERUM HSP 72 LEVELS IN BOTH HUMANS AND RODENTS FOLLOWING SYSTEMIC INFLAMMATION. In Shock (Vol. 21, pp. 84–84). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1097/00024382-200406002-00250

Singleton, K. D., T. R. Ziegler, M. Luo, C. Fernandez-Estivariz, and P. E. Wischmeyer. “INTRAVENOUS GLUTAMINE INCREASES SERUM HSP 72 LEVELS IN BOTH HUMANS AND RODENTS FOLLOWING SYSTEMIC INFLAMMATION.” In Shock, 21:84–84. Ovid Technologies (Wolters Kluwer Health), 2004. https://doi.org/10.1097/00024382-200406002-00250.

Singleton KD, Ziegler TR, Luo M, Fernandez-Estivariz C, Wischmeyer PE. INTRAVENOUS GLUTAMINE INCREASES SERUM HSP 72 LEVELS IN BOTH HUMANS AND RODENTS FOLLOWING SYSTEMIC INFLAMMATION. In: Shock. Ovid Technologies (Wolters Kluwer Health); 2004. p. 84–84.

Singleton, K. D., et al. “INTRAVENOUS GLUTAMINE INCREASES SERUM HSP 72 LEVELS IN BOTH HUMANS AND RODENTS FOLLOWING SYSTEMIC INFLAMMATION.” Shock, vol. 21, Ovid Technologies (Wolters Kluwer Health), 2004, pp. 84–84. Crossref, doi:10.1097/00024382-200406002-00250.

Singleton KD, Ziegler TR, Luo M, Fernandez-Estivariz C, Wischmeyer PE. INTRAVENOUS GLUTAMINE INCREASES SERUM HSP 72 LEVELS IN BOTH HUMANS AND RODENTS FOLLOWING SYSTEMIC INFLAMMATION. Shock. Ovid Technologies (Wolters Kluwer Health); 2004. p. 84–84.